Meinian Onehealth Hits Day Low of CNY 4.51 Amid Price Pressure

Meinian Onehealth Healthcare Holdings Co., Ltd. experienced a significant decline today, with the stock dropping by 5.03% and reaching an intraday low of CNY 4.51. This performance stands in contrast to the broader market, as the China Shanghai Composite index fell by 3.05% during the same period. Over the past month, Meinian Onehealth has seen a decrease of 13.38%, while its year-to-date performance reflects a decline of 14.2%. The company has reported negative financial results for the first quarter of 2026, with a pre-tax profit of CNY -278.08 million, marking a substantial drop of 316.01%. Additionally, net profit fell to CNY -249.87 million, a staggering decline of 479.44%. Despite being net-debt free, the company has struggled with long-term growth, as evidenced by a modest annual sales growth rate of 3.42% and an operating profit growth rate of 12.62% over the past five years. With a return on equity of 4.85% and a price-to-book ratio of 2.51, the stock's valuation appears elevated relative to its profitability metrics.